A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers ...

A major breakthrough in the treatment of an aggressive form of leukemia is bringing new hope to patients and it started in ...

Professor Waseem Qasim told LBC News the breakthrough demonstrates "the power and the potential" of emerging technologies ...

Terns also expects to grant underwriters a 30-day option to buy up to an additional $60 million of shares. Later on Wednesday, Terns said it would price a separate public offering of 16.3 million ...

Adult patients with an aggressive form of leukemia will be able to receive a breakthrough immunotherapy, which was invented ...

PVEK, a CD123-targeting antibody-drug conjugate, demonstrated strong response rates in two studies. Combined with VEN/AZA, it ...

MONTREAL, Dec. 10, 2025 /CNW/ - Novartis Canada is pleased to announce that Scemblix ® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario's new Funding ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Pediatric cancer is rare, but if your child or someone you know gets sick, having the right kind of treatment is critical.

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Incyte ( INCY) on Sunday said the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...